This statistic displays the annual spending on biosimilars in the United States in 2014, by type. During this year, 8.6 billion U.S. dollars that were spent on insulins were to expire between 2015 and 2019. In 2009, the Biologics Price Competition and Innovation Act established a biosimilar pathway which has led to several applications and approvals.
Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IMS Health. (April 30, 2015). Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)* [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/448232/expenditures-in-us-on-biosimilars-by-type/
IMS Health. "Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*." Chart. April 30, 2015. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/448232/expenditures-in-us-on-biosimilars-by-type/
IMS Health. (2015). Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/448232/expenditures-in-us-on-biosimilars-by-type/
IMS Health. "Expenditure on Biosimilars in The United States in 2014, by Type (in Billion U.S. Dollars)*." Statista, Statista Inc., 30 Apr 2015, https://www.statista.com/statistics/448232/expenditures-in-us-on-biosimilars-by-type/
IMS Health, Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/448232/expenditures-in-us-on-biosimilars-by-type/ (last visited December 21, 2024)
Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)* [Graph], IMS Health, April 30, 2015. [Online]. Available: https://www.statista.com/statistics/448232/expenditures-in-us-on-biosimilars-by-type/
